Intrinsic Value of S&P & Nasdaq Contact Us

AptarGroup, Inc. ATR NYSE

NYSE • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
67/100
4/7 Pass
SharesGrow Intrinsic Value
$204.50
+57.7%
Analyst Price Target
$169.67
+30.9%

AptarGroup, Inc. (ATR) reported total assets of $5.25B and total liabilities of $2.54B for quarter ending 2025-12-31, resulting in total equity of $2.71B.

The company held $409.53M in cash and short-term investments. Total debt stood at $1.53B, with net debt of $1.13B. The Debt-to-Equity (D/E) ratio was 0.56 (moderate).

Current ratio is 1.62, indicating strong short-term liquidity. Interest coverage is 6.6x (adequate).

Criteria supported by this page:

  • HEALTH (83/100, Pass) — Debt-to-Equity of 0.56, current ratio of 1.62, interest coverage 6.6x — balance sheet is strong
  • MOAT (38/100) — Total assets $5.25B and equity $2.71B support the company's competitive scale
  • VALUE (78/100) — Debt-to-Equity 0.56 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 67/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
67/100
SG Score
View full scorecard →
VALUE
78/100
Price-to-Earnings & upside
→ Valuation
~
FUTURE
52/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
HEALTH
83/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
38/100
Proven by this page
GROWTH
63/100
→ Income
~
INCOME
55/100
→ Income
AptarGroup, Inc. Balance Sheet History
Metric Q4 FY2025 Q3 FY2025 Q2 FY2025 Q1 FY2025
Total Assets $5.25B$5.1B$4.87B$4.53B
Total Liabilities $2.54B$2.29B$2.15B$1.98B
Total Debt $1.53B$1.25B$1.14B$1.06B
Cash & Investments $409.53M$264.82M$169.77M$136.82M
Total Stockholders Equity $2.67B$2.8B$2.7B$2.55B
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message